GlyEco (OTCMKTS:GLYE – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability.
Profitability
This table compares GlyEco and ASP Isotopes’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
GlyEco | N/A | N/A | N/A |
ASP Isotopes | N/A | -174.89% | -68.75% |
Institutional and Insider Ownership
16.8% of ASP Isotopes shares are held by institutional investors. 22.1% of GlyEco shares are held by insiders. Comparatively, 21.4% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
GlyEco | 0 | 0 | 0 | 0 | 0.00 |
ASP Isotopes | 0 | 0 | 3 | 0 | 3.00 |
ASP Isotopes has a consensus price target of $4.50, suggesting a potential downside of 43.04%. Given ASP Isotopes’ stronger consensus rating and higher probable upside, analysts clearly believe ASP Isotopes is more favorable than GlyEco.
Earnings and Valuation
This table compares GlyEco and ASP Isotopes”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
GlyEco | N/A | N/A | N/A | N/A | N/A |
ASP Isotopes | $430,000.00 | 1,307.36 | -$16.29 million | ($0.63) | -12.54 |
GlyEco has higher earnings, but lower revenue than ASP Isotopes.
Summary
ASP Isotopes beats GlyEco on 5 of the 8 factors compared between the two stocks.
About GlyEco
GlyEco, Inc. engages in the development and manufacture of coolants, additives and related performance fluids. Its products and services include additives, ethylene glycol and antifreeze. The company was founded by Janet Carnell Lorenz, John Darc Lorenz, II and Todd L. Smith on April 21, 1997 and is headquartered in Rock Hill, SC.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Receive News & Ratings for GlyEco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlyEco and related companies with MarketBeat.com's FREE daily email newsletter.